Brightstone Venture Capital

Brightstone Venture Capital is a Minneapolis-based venture capital firm with a strong focus on early-stage technology and life science companies. Established in 2000, the firm has built a reputation for partnering with bold entrepreneurs who are developing innovative and disruptive solutions. Their investment philosophy centers on identifying companies with significant growth potential across various high-impact sectors.

The firm typically engages in Seed, Series A, and Series B funding rounds, providing crucial capital during the formative stages of a company's development. Brightstone's initial investments generally range from $500,000 to $3,000,000, indicating a preference for substantial early-stage commitments that can fuel significant progress. While they maintain a primary focus on opportunities within the Midwest, their investment scope extends nationally for exceptionally promising ventures that align with their strategic objectives.

Brightstone's portfolio spans a diverse array of technology and life science sub-sectors, including but not limited to Software, SaaS, Artificial Intelligence/Machine Learning, Cybersecurity, Fintech, Digital Health, Biotechnology, Medtech, and Diagnostics. This broad yet specialized approach allows them to capitalize on emerging trends and support a wide spectrum of innovation. Beyond initial funding, Brightstone also strategically reserves capital for follow-on investments, demonstrating a long-term commitment to their portfolio companies' growth and success. Their two decades of experience since their founding in 2000 underscore a seasoned approach to venture capital, aiming to foster the development of market-leading enterprises.